Use of Cancer Survivorship Care Guidelines by Primary Care Providers in the United States

• Published in: Journal of the American Board of Family Medicine Vol. 36; no. 5; pp. 789 - 802
• Main Authors: Townsend, Julie S, Rohan, Elizabeth A, Sabatino, Susan A, Puckett, Mary
• Format: Journal Article
• Language: English
• Published: United States 11.10.2023
• Subjects: Cancer Survivors; Humans; Neoplasms - therapy; Physicians, Primary Care; Primary Health Care; Survivorship; United States; United States; Cancer Survivors; Logistic Regression; Clinical Guidelines; Disease Management; Primary Health Care; Survivorship; Cancer
• ISSN: 1557-2625; 1558-7118
• DOI: 10.3122/jabfm.2023.230036R1

National organizations have issued comprehensive cancer survivorship care guidelines to improve care of cancer survivors, many of whom receive care from primary care providers (PCPs). We analyzed Porter Novelli's 2019 fall DocStyles survey to assess use of cancer survivorship care guidelines, receipt of survivorship training, types of survivorship services provided, and confidence providing care among PCPs in the United States. We grouped PCPs by use of any guideline ("users") versus no guideline use ("nonusers"). We calculated descriptive statistics and conducted multivariable logistic regression analyses to examine guideline use, having received training on providing survivorship care services, and confidence in providing care. Within the panel, sampling quotas were set so that 1000 primary care physicians, 250 OB/GYNs, 250 pediatricians, and 250 nurse practitioners/physician assistants were recruited. To reach selected quotas, 2696 health professionals were initially contacted to participate, resulting in a response rate of 64.9%. Sixty-two percent of PCPs reported using guidelines and 17% reported receiving survivorship care training. Use of any guidelines or receiving training was associated with reporting providing a range of survivorship services and confidence in providing care. After adjusting for demographic characteristics, guideline users were more likely than nonusers to report assessing genetic cancer risk (OR = 2.65 95% confidence interval (CI) (1.68, 4.17)), screening for cancer recurrence (OR = 2.32 95% CI (1.70, 3.18)) or a new cancer (OR = 1.63, 95% CI (1.20, 2.22)), and treating depression (OR = 1.64, 95% CI (1.20, 2.25)). Receipt of training was also positively associated with providing genetic risk assessment, surveillance for recurrence, as well as assessing late/long-term effects, and treating pain, fatigue, and sexual side effects. Survivorship care guidelines and training support PCPs in providing a range of survivorship care services.